AU655544B2 - Azole compounds, their production and use - Google Patents

Azole compounds, their production and use Download PDF

Info

Publication number
AU655544B2
AU655544B2 AU38221/93A AU3822193A AU655544B2 AU 655544 B2 AU655544 B2 AU 655544B2 AU 38221/93 A AU38221/93 A AU 38221/93A AU 3822193 A AU3822193 A AU 3822193A AU 655544 B2 AU655544 B2 AU 655544B2
Authority
AU
Australia
Prior art keywords
compound
salt
difluorophenyl
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU38221/93A
Other languages
English (en)
Other versions
AU3822193A (en
Inventor
Katsumi Itoh
Kenji Okonogi
Norikazu Tamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU3822193A publication Critical patent/AU3822193A/en
Application granted granted Critical
Publication of AU655544B2 publication Critical patent/AU655544B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymerization Catalysts (AREA)
  • Coloring (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU38221/93A 1992-04-28 1993-04-27 Azole compounds, their production and use Ceased AU655544B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP11040092 1992-04-28
JP4-110400 1992-04-28
JP2262393 1993-02-10
JP5-22623 1993-02-10

Publications (2)

Publication Number Publication Date
AU3822193A AU3822193A (en) 1993-11-04
AU655544B2 true AU655544B2 (en) 1994-12-22

Family

ID=26359882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38221/93A Ceased AU655544B2 (en) 1992-04-28 1993-04-27 Azole compounds, their production and use

Country Status (18)

Country Link
US (2) US5371101A (OSRAM)
EP (1) EP0567982B1 (OSRAM)
JP (1) JP2818097B2 (OSRAM)
KR (1) KR100257619B1 (OSRAM)
CN (1) CN1040433C (OSRAM)
AT (1) ATE167857T1 (OSRAM)
AU (1) AU655544B2 (OSRAM)
CA (1) CA2094962A1 (OSRAM)
DE (1) DE69319380T2 (OSRAM)
DK (1) DK0567982T3 (OSRAM)
ES (1) ES2118160T3 (OSRAM)
FI (1) FI931901A7 (OSRAM)
HU (2) HUT64327A (OSRAM)
NO (1) NO303284B1 (OSRAM)
NZ (1) NZ247488A (OSRAM)
PH (1) PH31082A (OSRAM)
SG (1) SG48939A1 (OSRAM)
TW (1) TW218017B (OSRAM)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212458B (en) * 1993-09-23 1996-06-28 Richter Gedeon Vegyeszet New silyloxypropane derivatives substituted with triazole or imidazole pharmaceutical compositions containing them and process for producing them
TW297813B (OSRAM) * 1993-09-24 1997-02-11 Takeda Pharm Industry Co Ltd
CA2134417A1 (en) * 1993-12-22 1995-06-23 Katsumi Itoh Optically active azole derivatives, their production and use
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
EP0746318A1 (en) * 1994-02-25 1996-12-11 Takeda Chemical Industries, Ltd. Injectable emulsions containing antifungal triazole derivatives
US5677464A (en) * 1994-05-31 1997-10-14 Takeda Chemical Industries, Ltd. Production of optically active triazole compounds and their intermediates
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
TW318841B (OSRAM) 1995-02-17 1997-11-01 Takeda Pharm Industry Co Ltd
CA2211458A1 (en) * 1995-02-17 1996-08-22 Kenji Okonogi Azole compounds, their production and use
US6060604A (en) 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US5700825A (en) * 1995-03-31 1997-12-23 Florida State University Radiosensitizing diamines and their pharmaceutical preparations
DE19520597A1 (de) * 1995-06-06 1996-12-12 Bayer Ag Mercapto-bis-triazole
MX9702382A (es) * 1995-08-02 1998-02-28 Uriach & Cia Sa J Nuevos derivados de pirimidona con actividad antifungica.
WO1997005131A1 (en) * 1995-08-02 1997-02-13 J. Uriach & Cia. S.A. New carboxamides with antifungal activity
ES2120885B1 (es) * 1996-03-15 1999-06-16 Uriach & Cia Sa J Nuevas tienopirimidonas con actividad antifungica.
ES2107376B1 (es) * 1995-08-02 1998-07-01 Uriach & Cia Sa J Nuevos derivados de pirimidona con actividad antifungica.
GB9602080D0 (en) 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2250353A1 (en) * 1996-04-03 1997-10-09 Christopher J. Dinsmore Inhibitors of farnesyl-protein transferase
AU6119798A (en) * 1997-03-05 1998-09-22 Takeda Chemical Industries Ltd. Crystalline form of a bis 1,2,4-triazole compound
AU6520098A (en) 1997-03-31 1998-10-22 Takeda Chemical Industries Ltd. Azole compounds, their production and their use
EP0884311A3 (en) * 1997-06-06 1999-01-27 Takeda Chemical Industries, Ltd. Triazole Derivatives and their production
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
WO2000018401A1 (fr) * 1998-09-29 2000-04-06 Takeda Chemical Industries, Ltd. Composition de medicament antimycotique
NZ521241A (en) * 2000-03-07 2004-02-27 Ranbaxy Lab Ltd Azole compounds as therapeutic agents for fungal infections
IN191188B (OSRAM) 2000-03-07 2003-10-04 Ranbaxy Lab Ltd
ES2159488B1 (es) * 2000-03-07 2002-04-16 Uriach & Cia Sa J Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
MXPA03005899A (es) 2000-12-26 2004-01-26 Ranbaxy Lab Ltd Compuestos azoles como agentes anti-micoticos.
JP2004524348A (ja) * 2001-03-23 2004-08-12 リチュテル・ゲデオン・ヴェジェーセティ・ジャール・エルテー フルコナゾールおよびその結晶変形の製造方法
IN191819B (OSRAM) * 2001-07-19 2004-01-03 Ranbaxy Lab Ltd
IN192526B (OSRAM) * 2001-09-25 2004-04-24 Ranbaxy Lab
US7028055B2 (en) * 2002-03-22 2006-04-11 Sun Microsystems, Inc. Method and apparatus for improving transaction specification by marking application states
US20050261330A1 (en) * 2002-04-12 2005-11-24 Mohammad Salman Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents
ATE521349T1 (de) 2002-06-18 2011-09-15 Pola Pharma Inc Antimykotische medizinische zusammensetzungen
WO2004018485A1 (en) * 2002-08-26 2004-03-04 Ranbaxy Laboratories Limited Azole derivatives as antifungal agents
KR100572996B1 (ko) * 2003-08-12 2006-04-25 한국화학연구원 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
ME01498B (me) 2004-11-18 2014-04-20 Synta Pharmaceuticals Corp Jedinjenja triazola koja modulišu aktivnost hsp90
CN1304376C (zh) * 2005-03-04 2007-03-14 清华大学 一种卤化烷基咪唑型离子液体的制备方法
AU2006279794B2 (en) * 2005-08-12 2011-04-07 Synta Pharmaceuticals Corp. Pyrazole compounds that modulate HSP90 activity
TWI446910B (zh) * 2005-08-18 2014-08-01 Synta Pharmaceuticals Corp 調節hsp90活性的三唑化合物
US20080027047A1 (en) * 2006-05-25 2008-01-31 Weiwen Ying Compounds that modulate HSP90 activity and methods for identifying same
US8318790B2 (en) * 2006-05-25 2012-11-27 Synta Pharmaceuticals Corp. Triazole compounds that modulate HSP90 activity
CA2653329C (en) 2006-05-25 2018-01-16 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
EP2038262B1 (en) * 2006-05-25 2014-11-12 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
ES2652670T3 (es) 2006-08-07 2018-02-05 Palau Pharma, S.A. Compuestos antifúngicos cristalinos
CA2666489C (en) * 2006-10-19 2012-10-02 F. Hoffmann-La Roche Ag Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
US9205086B2 (en) 2010-04-19 2015-12-08 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
CN102824342B (zh) * 2011-06-17 2016-03-30 全哲山 一类用作抗癫痫药的化合物及其可药用盐
CA2853799A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
WO2013067165A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with platinum-containing agents
US9402831B2 (en) 2011-11-14 2016-08-02 Synta Pharmaceutical Corp. Combination therapy of HSP90 inhibitors with BRAF inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8306351D0 (en) * 1983-03-08 1983-04-13 Ici Plc Azole fungicides
DK159205C (da) * 1983-03-16 1991-03-04 Pfizer Bis(triazol)alkanol-forbindelser, anvendelse af disse, farmaceutiske praeparater og landbrugsfungicider indeholdende disse og fremgangsmaade til behandling af planter eller froe, som har en svampeinfektion
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
NO171272C (no) * 1988-03-04 1993-02-17 Sankyo Co Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser
DE3837463A1 (de) * 1988-11-04 1990-05-10 Bayer Ag Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
KR100257619B1 (en) 2000-07-01
ES2118160T3 (es) 1998-09-16
KR940005616A (ko) 1994-03-21
TW218017B (OSRAM) 1993-12-21
CN1040433C (zh) 1998-10-28
JP2818097B2 (ja) 1998-10-30
JPH06293740A (ja) 1994-10-21
US5371101A (en) 1994-12-06
NO931533L (no) 1993-10-29
FI931901L (fi) 1993-10-29
FI931901A7 (fi) 1993-10-29
NZ247488A (en) 1995-02-24
EP0567982B1 (en) 1998-07-01
DE69319380D1 (de) 1998-08-06
SG48939A1 (en) 1998-05-18
FI931901A0 (fi) 1993-04-27
HU9301226D0 (en) 1993-07-28
NO303284B1 (no) 1998-06-22
DE69319380T2 (de) 1998-10-29
ATE167857T1 (de) 1998-07-15
US5466820A (en) 1995-11-14
EP0567982A1 (en) 1993-11-03
CA2094962A1 (en) 1993-10-29
HUT64327A (en) 1993-12-28
CN1079467A (zh) 1993-12-15
PH31082A (en) 1998-02-05
HU211474A9 (en) 1995-11-28
DK0567982T3 (da) 1999-04-12
NO931533D0 (no) 1993-04-27
AU3822193A (en) 1993-11-04

Similar Documents

Publication Publication Date Title
AU655544B2 (en) Azole compounds, their production and use
US7151182B2 (en) Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives
CA2680292C (en) Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives
US5792780A (en) Azole compounds, their production and use
EP0641785B1 (en) Triazolylated tertiary amine compound or salt thereof
US6362206B1 (en) Azole compounds, their production and use
EP0659751A1 (en) Optically active azole derivatives, their production and use
US5389663A (en) 1-(1h-1,2,4-triazole-yl)-2-propanol compounds
JPH0649033A (ja) 光学活性アゾール化合物およびその用途
CA2211458A1 (en) Azole compounds, their production and use
CA2038201A1 (en) Triazoles, their production and use
JP3056412B2 (ja) アゾール化合物およびその用途
EP0341846B1 (en) Azole derivatives of spiroheterocycles
US5106409A (en) Azole derivatives of spiroheterocycles
AU726495B2 (en) N-benzylazolium derivatives
JPH08104676A (ja) アゾール化合物、その製造方法及び用途
JPH07228574A (ja) 光学活性アゾール誘導体、その製造方法及び用途

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired